Search Results
(±)19(20)-EpDPA 500 µg | ≥98%
Cayman Chemical
(±)19(20)-EpDPA 100 µg | ≥98%
Cayman Chemical
(±)19(20)-EpDPA 50 µg | ≥98%
Cayman Chemical
(±)19(20)-EpDPA 25 µg | ≥98%
Cayman Chemical
(±)19(20)-EpDPA 1 mg | Purity Not Available
TargetMol
EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators. Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as (±)14(15)-EpETrE which are prime candidates for the actual active mediator. However, the […]
More Information Supplier Page(±)19(20)-EpDTE 1 mg | Purity Not Available
TargetMol
(±)19(20)-EpDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid . It is formed via cytochrome P450 (CYP) metabolism of DPA and can be further metabolized to (±)19(20)-DiHDTE by epoxide hydrolase.
More Information Supplier Page

